Fortrea Holdings: Pay

Fortrea Holdings paid its 5 named executives $23.8M in total in FY2025 (Dec). CEO Anshul Thakral was paid $11.6M of that.

Pay$100 in the stock at the end of FY24 → $86
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Anshul ThakralChief Executive Officer
FY2025 (Dec)
1 year
Thomas PikeFormer Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Jill McConnellChief Financial Officer
FY2025 (Dec)
FY2022 (Dec)Not disclosed
2 years
Mark MoraisChief Operating Officer; President, Clinical Services
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Peter NeupertInterim Chief Executive Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 13 peers with pay on file was $9.0M. CEO pay of Fortrea Holdings for that year is not on file.

  1. 1Exelixis
  2. 2Iqvia Holdings
  3. 3Bausch Health Companies
  4. 4Charles River Laboratories International
  5. 5Medpace Holdings
  6. 6Integra Lifesciences Holdings
  7. 7PERRIGO Co
  8. 8Dentsply Sirona
  9. 9Alkermes plc.
  10. 10Vir Biotechnology
  11. 11Teleflex
  12. 12Organon & Co.
  13. 13Bruker
  14. 14Fortrea HoldingsNot disclosed
  15. 15Bausch + Lomb CorporationNot disclosed
  16. 16Bio-Rad LaboratoriesNot disclosed
  17. 17Catalent, Inc.Not disclosed
  18. 18Jazz PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.